Alzheimer-related affective symptoms–mechanism and treatment
Alzheimer's disease (AD) is the most common cause of dementia and the fifth leading cause
of death in adults older than 65. Aged individuals are disproportionately likely to suffer from …
of death in adults older than 65. Aged individuals are disproportionately likely to suffer from …
The road to personalized medicine in Alzheimer's disease: the use of artificial intelligence
A Silva-Spínola, I Baldeiras, JP Arrais, I Santana - Biomedicines, 2022 - mdpi.com
Dementia remains an extremely prevalent syndrome among older people and represents a
major cause of disability and dependency. Alzheimer's disease (AD) accounts for the …
major cause of disability and dependency. Alzheimer's disease (AD) accounts for the …
Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer's disease
Background: The only conclusive way to diagnose Alzheimer's is to carry out brain autopsy
of the patient's brain tissue and ascertain whether the subject had Alzheimer's or any other …
of the patient's brain tissue and ascertain whether the subject had Alzheimer's or any other …
Mechanisms of cognitive impairment in depression. May probiotics help?
M Dobielska, NK Bartosik, KA Zyzik… - Frontiers in …, 2022 - frontiersin.org
Depression is the major cause of disability globally. Apart from lowered mood and
accompanying symptoms, it leads to cognitive impairment that altogether predicts …
accompanying symptoms, it leads to cognitive impairment that altogether predicts …
Pathobiological targets of depression
K Chopra, B Kumar, A Kuhad - Expert opinion on therapeutic …, 2011 - Taylor & Francis
Introduction: Depression is one of the most prevalent and life-threatening forms of mental
illness associated with significant disability and mortality. About 21% of the world's …
illness associated with significant disability and mortality. About 21% of the world's …
Neurobiology of depression and novel antidepressant drug targets
N Kern, AJ Sheldrick, FM Schmidt… - Current pharmaceutical …, 2012 - ingentaconnect.com
Depression is one of the most common psychiatric conditions affecting numerous individuals
in the world. However, the currently available antidepressant medication shows low …
in the world. However, the currently available antidepressant medication shows low …
Future prospects in depression research
PE Holtzheimer III, CB Nemeroff - Dialogues in clinical …, 2006 - Taylor & Francis
Major depression is a common, disabling, and often difficult-to-treat illness. Decades of
research into the neurobiology and treatment of depression have greatly advanced our …
research into the neurobiology and treatment of depression have greatly advanced our …
Blues in the brain and beyond: molecular bases of major depressive disorder and relative pharmacological and non-pharmacological treatments
E Maffioletti, A Minelli, D Tardito, M Gennarelli - Genes, 2020 - mdpi.com
Despite the extensive research conducted in recent decades, the molecular mechanisms
underlying major depressive disorder (MDD) and relative evidence-based treatments …
underlying major depressive disorder (MDD) and relative evidence-based treatments …
Advances in depression research: second special issue, 2020, with highlights on biological mechanisms, clinical features, co-morbidity, genetics, imaging, and …
The current speed of progress in depression research is simply remarkable. We have
therefore been able to create a second special issue of Molecular Psychiatry, 2020, focused …
therefore been able to create a second special issue of Molecular Psychiatry, 2020, focused …
Future drugs for the treatment of depression: the need to look beyond monoamine systems
MH Rapaport - CNS spectrums, 2009 - cambridge.org
Review of extant biological data would suggest that major depressive disorder (MDD) is a
term used to subsume a syndrome that may involve a variety of different pathophysiological …
term used to subsume a syndrome that may involve a variety of different pathophysiological …